Sun Pharmaceutical Industries rose 2.91% to Rs 404.80, extending recent gains on strong buying support.
Shares of Sun Pharmaceutical Industries rallied 9.74% in two trading sessions to its current market price of Rs 404.80 from its recent closing low of Rs 368.85 on Monday, 2 March 2020.
On the technical front, the stock's RSI (relative strength index) stood at 48.842. The RSI oscillates between zero and 100. Traditionally the RSI is considered overbought when above 70 and oversold when below 30.
The stock was trading between its 20-day moving average (DMA) placed at Rs 404.68 and 50-day moving average (DMA) placed at Rs 426.08.
Sun Pharmaceutical Industries' consolidated net profit tanked 26.4% to Rs 913.52 crore on a 5% increase in net sales to Rs 8,038.65 crore in Q3 December 2019 over Q3 December 2018.
Sun Pharmaceutical Industries' business segments include US Business, Indian branded generics business, Emerging markets, Global consumer healthcare business and Active Pharmaceutical Ingredients (API).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app